Authors: Eng Hooi Tan, Anthony G. Sena, Albert Prats-Uribe, Seng Chan You, Waheed-Ul-Rahman Ahmed, Kristin Kostka, Christian G. Reich, Scott L. DuVall, Kristine E. Lynch, Michael E. Matheny, Talita Duarte-Salles, Sergio Fernandez Bertolin, George Hripcsak, Karthik Natarajan, Thomas Falconer, Matthew E. Spotnitz, Anna Ostropolets, Clair Blacketer, Thamir M. Alshammari, Heba Alghoul, Osaid Alser, Jennifer C E Lane, Dalia Dawoud, Karishma Shah, Yue Yang, Lin Zhang, Carlos Areia, Asieh Golozar, Martina Recalde, Paula Casajust, Jitendra Jonnagaddala, Vignesh Subbian, David Vizcaya, Lana Yin Hui Lai, Fredrik Nyberg, Daniel R. Morales, Jose D. Posada, Nigam H. Shah, Mengchun Gong, Arani Vivekanantham, Aaron Abend, Evan P. Minty, Marc A. Suchard, Peter R. Rijnbeek, Patrick B. Ryan, Daniel Prieto-Alhambra
Venue: Rheumatology
Type: Publication
Abstract: Patients with autoimmune diseases were advised to shield to avoid COVID-19, but information on their prognosis is lacking. We characterised 30-day outcomes and mortality after hospitalisation with COVID-19 among patients with prevalent autoimmune diseases, and compared outcomes after hospital admissions among similar patients with seasonal influenza.Multinational network cohort study.Electronic health records data from Columbia University Irving Medical Center (CUIMC) (NYC, United States [US]), Optum [US], Department of Veterans Affairs (VA) (U...
(read more)
Topics: 
Internal medicine
Pediatrics
Loading (it may take a couple of seconds)...
Loading (it may take a couple of seconds)...